Clinical Trials Logo

Clinical Trial Summary

Noncardiac chest pain (NCCP) is a common clinical problem worldwide. In Hong Kong, it has been estimated that about 20% of patients with chest pain are misdiagnosed to have coronary heart disease. Despite its benign nature, this condition causes anxiety, impairs quality of life and consumes a substantial amount of healthcare resources. While acid reflux and motility disorder in the esophagus are often attributed as the cause of NCCP, visceral hyperalgesia of esophagus is now recognized to play a central role in the pathogenesis of this condition. This research project aims to evaluate the role of visceral hyperalgesia in Chinese patients with NCCP. NCCP patients will be evaluated for the prevalence of gastroesophageal reflux disease and esophageal motility disorder by endoscopy, manometry and pH study. The visceral sensory and pain thresholds of these patients will be compared with asymptomatic controls.


Clinical Trial Description

n/a


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00164814
Study type Observational
Source Chinese University of Hong Kong
Contact
Status Terminated
Phase N/A

See also
  Status Clinical Trial Phase
Terminated NCT00164801 - Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese? N/A
Completed NCT03336112 - Internet-delivered CBT for Patients With NCCP N/A
Recruiting NCT06136494 - iCBT for Cardiac Anxiety in Patients With NCCP N/A
Completed NCT00373828 - Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis. N/A
Completed NCT00476398 - Evaluation of Patients With Non-cardiac Chest Pain Phase 4
Completed NCT00462241 - Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain N/A